Nuclear Factor Kappa B and Cyclo-Oxygenase-2: Two Concordant Players in Psoriasis Pathogenesis

References

• Naldi L. Epidemiology of psoriasis. Curr Drug Targets Inflamm Allergy 2004;3: 121–8
   PubMedGoogle Scholar
• Griffiths C, Camp R, Barker J. Psoriasis. In: Burns T, Breathnach S, Cox N, eds. Rook’s textbook of dermatology, 7th ed. Oxford: Blackwell Company, 2004:1–69
   Google Scholar
• Chaudhari U, Romano P, Mulcahy LD, et al. Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: A randomised trial. Lancet 2001;357: 1842–7
   PubMed Web of Science ®Google Scholar
• Baldwin AS Jr. The NF-kappa B and I kappa B proteins: New discoveries and insights. Annu Rev Immunol 1996;14: 649–83
   PubMed Web of Science ®Google Scholar
• Zhong H, Voll RE, Ghosh S. Phosphorylation of NF-kappa B p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300. Mol Cell 1998;1: 661–71
   PubMed Web of Science ®Google Scholar
• Sonenshein GE. Rel/NF-kappa B transcription factors and the control of apoptosis. Semin Cancer Biol 1997;8: 113–19
   PubMed Web of Science ®Google Scholar
• Ghosh S, May M, Kopp E. NF-kB and Rel proteins: Evolutionarily conserved mediators of immune responses. Annu Rev Immunol 1998;16: 225–60
   PubMed Web of Science ®Google Scholar
• Tak PP, Firestein GS. NF-kappa B: A key role in inflammatory diseases. J Clin Invest 2001;107: 7–11
   PubMed Web of Science ®Google Scholar
• Williams CS, Mann M, DuBois RN. The role of cyclooxygenases in inflammation, cancer, and development. Oncogene 1999;18: 7908–16
   PubMed Web of Science ®Google Scholar
• Samad TA, Moore KA, Sapirstein A, et al. Interleukin-1 β-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity. Nature 2001;6827: 471–5
   Google Scholar
• Tanabe T, Tohnai N. Cyclooxygenase isozymes and their gene structures and expression. Prostaglandins Other Lipid Mediat 2002;69: 95–14
   Google Scholar
• Louden BA, Pearce DJ, Lang W, et al. A simplified Psoriasis Ares Severity Index (SPASI) for rating psoriasis severity in clinic patients. Dermatol Online J 2004;10: 7–15
   PubMedGoogle Scholar
• Plewka A, Madej P, Plewka D, et al. Immunohistochemical localization of selected pro-inflammatory factors in uterine myomas and myometrium in women of various ages. Folia Histochem Cytobiol 2013;51: 73–83
   PubMed Web of Science ®Google Scholar
• Jo HY, Kim CK, Suh IB, et al. Co-localization of inducible nitric oxide synthase and phosphorylated Akt in the lesional skins of patients with melasma. J Dermatol 2009;36: 10–16
   Google Scholar
• Bilalovic N, Sandstad B, Golouh R, et al. CD10 protein expression in tumor and stromal cells of malignant melanoma is associated with tumor progression. Mod Pathol 2004;17: 1251–8
   PubMed Web of Science ®Google Scholar
• Samaka RM, Abdou AG, Abd Elwahed MM, et al. Cyclooxygenase-2 expression in chronic gastritis and gastric carcinoma, correlation with prognostic parameters. J Egypt Nat Cancer Inst 2006;18: 363–74
   Google Scholar
• Ermert L, Dierkes C, Ermert M. Immunohistochemical expression of COX-2 isoenzymes and downstream enzymes in human lung. Clin Cancer Res 2003;9: 1604–10
   PubMed Web of Science ®Google Scholar
• Seitz CS, Deng H, Hinata K, et al. Nuclear factor kappa B subunits induce epithelial cell growth arrest. Cancer Res 2000;60: 4085–92
   PubMed Web of Science ®Google Scholar
• Phal HL. Activators and target genes of Rel/NF-kappa B transcription factors. Oncogene 1999;18: 6853–66
   Google Scholar
• Doger FK, Dikicioglu E, Ergin F, et al. Nature of cell kinetics in psoriatic epidermis. J Cutan Pathol 2007;34: 257–63
   Google Scholar
• Abdou AG, Hanout HM. Evaluation of survivin and NF-κB in psoriasis, an immunohistochemical study. J Cutan Pathol 2008;35: 445–51
   PubMed Web of Science ®Google Scholar
• Lizzul PF, Aphale A, Malaviya R, et al. Differential expression of phosphorylated NF-kappaB/RelA in normal and psoriatic epidermis and downregulation of NF-kappaB in response to treatment with etanercept. J Invest Dermatol 2005;124: 1275–83
   PubMed Web of Science ®Google Scholar
• El-Enani G, Hunter N, El Hadidi H, et al. The expression of NF-κB in mycosis fungoides before and after photochemotherapy. J Egypt Wom Dermatol Soc 2009;6: 28–33
   Google Scholar
• Wrone-Smith T, Mitra RS, Thompson CB, et al. Keratinocytes derived from psoriatic plaques are resistant to apoptosis compared with normal skin. Am J Pathol 1997;151: 1321–9
   PubMed Web of Science ®Google Scholar
• Bell S, Degitz K, Quirling M, et al. Involvement of NFkB signaling in skin physiology and disease. Cell Signal 2002;15: 1–7
   Google Scholar
• Lippens S, Hoste E, Vandenabeele P, et al. Cell death in the skin. Apoptosis 2009;14: 549–69
   PubMed Web of Science ®Google Scholar
• Aktan F. iNOS-mediated nitric oxide production and its regulation. Life Sci 2004;75: 639–53
   PubMed Web of Science ®Google Scholar
• Bata-Csorgo Z, Hammerberg C, Voorhees JJ, et al. Kinetics and regulation of human keratinocyte stem cell growth in short-term primary ex vivo culture. Cooperative growth factors from psoriatic lesional T lymphocytes stimulate proliferation among psoriatic uninvolved, but not normal, stem keratinocytes. J Clin Invest 1995;95: 317–27
   PubMed Web of Science ®Google Scholar
• Werner S, Smola H. Paracrine regulation of keratinocyte proliferation and differentiation. Trends Cell Biol 2001;4: 143–6
   Google Scholar
• Kaufman CK, Fuchs E. It’s got you covered. NF-Kappa B in the epidermis. J Cell Biol 2000;149: 999–1004
   PubMed Web of Science ®Google Scholar
• Tsuruta D. NF-kappa B links keratinocytes and lymphocytes in the pathogenesis of psoriasis. Recent Pat Inflamm Allergy Drug Discov 2009;3: 40–8
   PubMedGoogle Scholar
• Begon E, Michel L, Flageul B, et al. Expression, subcellular localization and cytokinic modulation of Toll-like receptors (TLRs) in normal human keratinocytes: TLR2 up-regulation in psoriatic skin. Eur J Dermatol 2007;17: 497–506
   PubMed Web of Science ®Google Scholar
• Salskov-Iversen ML, Johansen C, Kragballe K, et al. Caspase-5 expression is upregulated in lesional psoriatic skin. J Invest Dermatol 2011;131: 670–6
   PubMed Web of Science ®Google Scholar
• Weinstein GD, McCullough JL, Ross PA. Cell kinetic basis for pathophysiology of psoriasis. J Invest Dermatol 1985;85: 579–83
   PubMedGoogle Scholar
• Saunders NA, Jetten AM. Control of growth regulatory and differentiation-specific genes in human epidermal keratinocytes by interferon gamma. Antagonism by retinoic acid and transforming growth factor beta 1. J Biol Chem 1994;269: 2016–22
   PubMed Web of Science ®Google Scholar
• Baker BS, Powles AV, Valdimarsson H, et al. An altered response by psoriatic keratinocytes to gamma interferon. Scand J Immunol 1998;28: 735–40
   Google Scholar
• McKenzie RC, Sabin E, Szepietowski JC, et al. Interferon gamma in keratinocytes in psoriasis. Eur J Dermatol 2003;13: 315–16
   PubMedGoogle Scholar
• Li Q, Verma IM. NF-κB regulation in the immune system. Nat Rev Immunol 2002;2: 725–34
   PubMed Web of Science ®Google Scholar
• Peek RM Jr, Blaser MJ. Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat Rev Cancer 2002;2: 28–37
   PubMed Web of Science ®Google Scholar
• Joyce D, Albanese C, Steer J, et al. NFκB and cell-cycle regulation: The cyclin connection. Cytokine Growth Factor Rev 2001;12: 73–90
   PubMed Web of Science ®Google Scholar
• Sugimoto M, Arai N, Futaki Y. Role of COX-1 and COX-2 on skin PGs biosynthesis by mechanical scratching in mice, Prostaglandins. Leukot Essent Fatty Acids 2006;75: 1–8
   PubMed Web of Science ®Google Scholar
• Simon L. Role and regulation of cyclooxygenase-2 during inflammation. Am J Mol 1999;106: 37–42
   PubMedGoogle Scholar
• Smith W, Garavito R, Dewitt D. Prostaglandin endoperxide Hsynthase (cyclooxygenases-1 and -2). J Biol Chem 1996;271: 33157–60
   PubMed Web of Science ®Google Scholar
• Ikai K. Psoriasis and the arachidonic acid cascade. J Dermatol Sci 1999;21: 135–46
   PubMed Web of Science ®Google Scholar
• Leong J, Hughes-Fulford M, Rakhlin N, et al. Cyclooxygenases in human and mouse skin and cultured human keratinocytes: Association of COX-2 expression with human keratinocyte differentiation. Exp Cell Res 1996;224: 79–87
   PubMed Web of Science ®Google Scholar
• Vogt T, McClelland M, Jung B, et al. Progression and NSAID-induced apoptosis in malignant melanomas are independent of cyclooxygenase II. Melanoma Res 2001;11: 587–99
   PubMed Web of Science ®Google Scholar
• Kagoura M, Toyoda M, Matsui C, et al. Immunohistochemical expression of cyclooxygenase-2 in skin cancers. J Cutan Pathol 2001;28: 298–302
   PubMed Web of Science ®Google Scholar
• An KP, Athar M, Tang X, et al. Cyclooxygenase-2 expression in murine and human nonmelanoma skin cancers: Implications for therapeutic approaches. Photochem Photobiol 2002;76: 73–80
   PubMed Web of Science ®Google Scholar
• Scholz K, Fürstenberger G, Müller-Decker K, Marks F. Differential expression of prostaglandin-H synthase isoenzymes in normal and activated keratinocytes in vivo and in vitro. Biochem J 1995;309: 263–9
   Google Scholar
• Matsuura H, Sakaue M, Subbaramaiah K, et al. Regulation of cyclooxygenase-2 by interferon gamma and transforming growth factor alpha in normal human epidermal keratinocytes and squamous carcinoma cells. J Biol Chem 1999;274: 29138–48
   PubMed Web of Science ®Google Scholar
• Muller-Decker K, Hirschner W, Marks F, et al. The effects of cyclooxyenase isozyme inhibition on incisional wound healing in mouse skin. J Invest Dermatol 2002;119: 1189–95
   PubMed Web of Science ®Google Scholar
• Rhodes LE, Gledhill K, Masoodi M. The sunburn response in human skin is characterized by sequential eicosanoid profiles that may mediate its early and late phases. FASEB J 2009;23: 3947–56
   PubMed Web of Science ®Google Scholar
• Honda T, Matsuoka T, Ueta M, et al. Prostaglandin E(2)-EP(3) signaling suppresses skin inflammation in murine contact hypersensitivity. J Allergy Clin Immunol 2009;124: 809–18
   PubMed Web of Science ®Google Scholar
• Kudo I, Murakami M. Prostaglandin E synthase, a terminal enzyme for prostaglandin E2 biosynthesis. J Biochem Mol Biol 2005;38: 633–8
   PubMedGoogle Scholar
• Ueno N, Takegoshi Y, Kamei D. Coupling between cyclooxygenases and terminal prostanoid synthases. Biochem Biophys Res Commun 2005;338: 70–76
   PubMed Web of Science ®Google Scholar
• Honma Y, Arai I, Hashimoto Y, et al. Prostaglandin D2 and prostaglandin E2 accelerate the recovery of cutaneous barrier disruption induced by mechanical scratching in mice. Eur J Pharmacol 2005;518: 56–62
   Google Scholar
• Scott G, Leopardi S, Printup S, et al. Proteinase-activated receptor-2 stimulates prostaglandin production in keratinocytes: Analysis of prostaglandin receptors on human melanocytes and effects of PGE2 and PGF2alpha on melanocyte dendricity. J Invest Dermatol 2004;122: 1214–24
   PubMed Web of Science ®Google Scholar
• Scott G, Jacobs S, Leopardi S, et al. Effects of PGF2alpha on human melanocytes and regulation of the FP receptor by ultraviolet radiation. Exp Cell Res 2005;304: 407–16
   PubMed Web of Science ®Google Scholar
• Black AT, Gray JP, Shakarjian MP, et al. UVB light upregulates prostaglandin synthases and prostaglandin receptors in mouse keratinocytes. Toxicol Appl Pharmacol 2008;232: 14–24
   Google Scholar
• Nakajima S, Honda T, Sakata D, et al. Prostaglandin I2-IP signaling promotes Th1 differentiation in a mouse model of contact hypersensitivity. J Immunol 2010;184: 5595–603
   PubMedGoogle Scholar
• Munroe DG, Wang EY, Maclntyre JP, et al. Novel intracellular signalling function of prostaglandin H synthase-1 in NF-κB activation. J Inflamm 1995;45: 260–8
   Google Scholar
• Tsai MH, Lin ZC, Liang CJ, et al. Eupafolin inhibits PGE2 production and COX2 expression in LPS-stimulated human dermal fibroblasts by blocking JNK/AP-1 and Nox2/p47phox pathway. Toxicol Appl Pharmacol 2014;279: 240–51
   Google Scholar
• Szczeklik W, Sanak M, Szczeklik A. Functional effects and gender association of COX-2 gene polymorphism G-765C in bronchial asthma. J Allergy Clin Immunol 2004;114: 248–53
   PubMed Web of Science ®Google Scholar
• Rostami M, Kadivar M, Aznab M, et al. Influence of age and gender on association between -765G > C COX-2 genetic polymorphism and gastric adenocarcinoma risk: A case–control study in Iran. Gastroenterol Hepatol Bed Bench 2012;5: 29–34
   Google Scholar
• Lee JM, Shin J, Hyang R, et al. Cyclooxygenase-2 expression predicts prognosis in astrocytic tumors. J Korean Neurosurg Soc 2004;36: 437–42
   Google Scholar
• Appleby SB, Ristimaki A, Neilson K, et al. Structure of the human cyclo-oxygenase-2 gene. Biochem J 1994;302: 723–7
   PubMed Web of Science ®Google Scholar
• Subbaramaiah K, Norton L, Gerald W, Dannenberg AJ. Cyclooxygenase-2 is overexpressed in HER-2/neu-positive breast cancer: Evidence for involvement of AP-1 and PEA3. J Biol Chem 2002;277: 18649–57
   PubMed Web of Science ®Google Scholar